SPRY · ARS Pharmaceuticals, Inc. · Documents
Market Cap
$558.89M
Shares
99.45M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-07-17 | 2026-07-15 | |
| 8-K | 2026-07-07 | 2026-07-06 | |
| 8-K | 2026-06-25 | 2026-06-24 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-15 | — | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| DEF 14A | 2026-04-29 | 2026-06-24 | |
| 8-K | 2026-03-09 | — | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-09-29 | — | |
| 8-K | 2025-08-28 | 2025-08-13 | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-06-26 | 2025-06-25 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-02 | — | |
| DEF 14A | 2025-04-29 | 2025-06-25 | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2025-01-13 | — | |
| 10-Q/A | 2024-12-06 | 2024-09-30 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-11-12 | 2024-11-09 | |
| 8-K | 2024-10-15 | 2024-10-08 | |
| 8-K | 2024-09-23 | 2024-09-17 | |
| 8-K | 2024-08-12 | 2024-08-09 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-28 | 2024-06-27 | |
| 8-K | 2024-06-28 | — | |
| 8-K | 2024-06-21 | 2024-06-20 | |
| 8-K | 2024-05-10 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-26 | 2024-06-20 | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-03-07 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-09-25 | — | |
| 8-K | 2023-09-20 | 2023-09-19 | |
| 8-K | 2023-08-10 | — |
Showing 1–50 of 97 filings
Key facts
CIK
1671858
CUSIP
82835W108
13F (30d)
134 filings
134 filers
Visit website
Investor relations